Gianni Scappaticci, PharmD, BCOP, outlines a personalized, evidence-based approach to managing steroid-refractory chronic graft-versus-host disease (cGVHD) in a post–haploidentical transplant patient, highlighting the rationale for using ruxolitinib, belumosudil, or their combination based on disease progression and fibrotic features.
By sharpening our vaccine confidence skills and advocating for expanded immunization scopes of practice, we can help improve convenient vaccine access in the US.
CKD is a complication of diabetes. Emerging treatments aim to optimize management and reduce risks. Pharmacists are key in applying new evidence to clinical practice.
The use of outpatient pharmacy protocols for glucose testing and insulin administration supplies should be expanded to assist patients in the self-management of diabetes.
Katherine H. Saunders, MD, DABOM, explores the role of pharmacists in supporting long-term weight management with GLP-1 therapies, including strategies for counseling on lifestyle interventions, managing adverse effects, and ensuring patients receive individualized, evidence-based care.
SMOs offer a range of services, including site selection, patient recruitment, data management, regulatory compliance, and quality assurance.
Precision oncology represents an evolution in therapeutic practice.
Implementing these standards can be logistically challenging.
Data show these cases pose some of the most significant threats to patients and health systems.
With integrated specialty pharmacies enabling health systems to improve patient outcomes and lower total medical costs, every hospital will need a solution to support the growing number of patients on outpatient specialty medications.
Targeted therapies have greatly improved patient outcomes over the past 20 years.
One of the most important drivers of a patients’ uncontrolled hypertension is medication nonadherence.
It is the role of the pharmacist to ensure patients are adequately counseled on the adverse effects and potential harms of codeine.
The COVID-19 pandemic has created challenges and opportunities, and this requires agility and flexibility.
Successfully integrating biosimilars into practices requires careful planning and execution, as they impact virtually all aspects of a practice.
The COVID-19 pandemic highlighted the importance of managing infections properly globally and the need for stewardship networks among partners.
Vaccination provides an opportunity to prevent and treat herpes simplex virus infection.
32 public colleges with combined enrollment of more than 700,000 students must comply with law by January 2023.
Zongertinib shows promising efficacy and safety for HER2-mutant NSCLC, with a 71% response rate and low toxicity, paving the way for future treatments.
Pharmacists should continue to emphasize the vaccine’s effectiveness in preventing cancer and be prepared to address patient safety concerns.
Both indications for the CTLA-4 inhibitor were approved by the FDA in 2022.
Pharmacists are critically important in care delivery in their ability to influence patient success, patient-reported outcomes, and quality of life while reducing the burden on physicians and their clinical support teams.
Marc Humbert, MD, PhD, shared data that were presented at the ACC 2025 Scientific Sessions.
This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
Lisa Nodzon, PhD, ARNP, AOCNP; Katie Tobon, PharmD, BCOP; and Javier Pinilla-Ibarz, MD, PhD, share insight on strategies for the monitoring and management of BTK inhibitor–associated toxicities in CLL and review the importance of a multidisciplinary approach to treatment.
RSV can exacerbate asthma development by causing damage to the tissue in the airways, promoting inflammation and increasing airway hyper-responsiveness
Methods of treating cervical intraepithelial neoplasia are limited and invasive. The need for better treatments is clear; however, there are several promising therapies under development.
Derek Webb, PharmD, a community pharmacist and Virginia Board of Pharmacy member, provides comprehensive guidance on managing seasonal allergies, distinguishing between symptoms, and exploring treatment options for patients.
Students are being exposed to new patient experiences through collaboration with practitioners.